Q Fever News and Research

RSS

Huge Malaria vaccine trial in Malawi

This week the African nation of Malawi became one of the first of the planned three to launch a pilot trial for a novel vaccine against malaria. The news and the efforts were lauded by the World Health Organization (WHO).

24 Apr 2019

Febrile seizures following vaccination are self-resolving and not dangerous

New research from the University of Sydney has found the severity of febrile seizures following vaccination is no different to febrile seizures from another cause, such as from a virus, and that the majority of seizures are short-lived, self-resolving and don't require ongoing treatment.

24 Apr 2019

Dengue mosquito poses greatest danger of spreading Zika virus in Australia

Researchers at QUT and QIMR Berghofer Medical Research Institute have found that the dengue fever mosquito common to north and central Queensland poses the greatest danger of spreading the Zika virus in Australia.

23 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

As syphilis invades rural America, a fraying health safety net is failing to stop it

When Karolyn Schrage first heard about the "dominoes gang" in the health clinic she runs in Joplin, Mo., she assumed it had to do with pizza.

19 Apr 2019

Study: Measles outbreaks may become more frequent if vaccination rates continue to decline

In 2000, measles was declared to be eliminated in the United States, when no sustained transmission of the virus was seen in this country for more than 12 months.

19 Apr 2019

Europe under major threat from vector-borne diseases

Researchers presenting at ECCMID have warned that vector-borne diseases are on the rise and threatening to spread into many parts of Europe.

From ESCMID 15 Apr 2019

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

15 Apr 2019

Geographical range of vector-borne diseases expands rapidly, shows research

New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, Netherlands shows that the geographical range of vector-borne diseases such as chikungunya, dengue fever, leishmaniasis, and tick-borne encephalitis is expanding rapidly.

15 Apr 2019

Researchers describe a case of tick-borne relapsing fever in Mexico

Tick-Borne Relapsing Fever is a recurring fever caused by exposure to infected Borrelia bacteria.

12 Apr 2019

German Research Foundation recently approves new research unit

"Cytomegalovirus, beware of this new research group!" This could be the motto of a new research unit recently approved by the German Research Foundation. It is titled: "Advanced concepts in cellular control of cytomegalovirus ".

11 Apr 2019

Maryland researchers find four bat lineages that exhibit extreme longevity

University of Maryland researchers analyzed an evolutionary tree reconstructed from the DNA of a majority of known bat species and found four bat lineages that exhibit extreme longevity.

11 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

Why hay fever persists, despite low pollen counts

A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.

10 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019